Haseeb, M., Rifat, A., Mohammed, S. (2026). The Utility of Complete Blood Count Inflammatory Markers in First-Trimester Missed Miscarriage. , 14(1), 38-45. doi: 10.32894/kjms.2026.166628.1229
Mohammed Fatih Haseeb; Aseel Ghazi Rifat; Shlair Ibrahim Mohammed. "The Utility of Complete Blood Count Inflammatory Markers in First-Trimester Missed Miscarriage". , 14, 1, 2026, 38-45. doi: 10.32894/kjms.2026.166628.1229
Haseeb, M., Rifat, A., Mohammed, S. (2026). 'The Utility of Complete Blood Count Inflammatory Markers in First-Trimester Missed Miscarriage', , 14(1), pp. 38-45. doi: 10.32894/kjms.2026.166628.1229
Haseeb, M., Rifat, A., Mohammed, S. The Utility of Complete Blood Count Inflammatory Markers in First-Trimester Missed Miscarriage. , 2026; 14(1): 38-45. doi: 10.32894/kjms.2026.166628.1229
The Utility of Complete Blood Count Inflammatory Markers in First-Trimester Missed Miscarriage
1Department of Pathology, College of Medicine, University of Kirkuk, Kirkuk, Iraq
2Department of Obstetrics and Gynecology, College of Medicine, University of Kirkuk, Kirkuk, Iraq
3Department of Physiology, College of Medicine, University of Kirkuk, Kirkuk, Iraq
Abstract
Background: Missed miscarriage is defined by retention of a non-viable intrauterine pregnancy and may be associated with altered maternal inflammatory responses. Complete blood count (CBC)-derived inflammatory markers may serve as simple indicators of adverse early pregnancy outcomes. This study evaluated the utility of CBC-derived inflammatory markers in first-trimester missed miscarriage. Methods: This retrospective case–control study included 150 pregnant women: 50 with missed miscarriage and 100 with viable pregnancies. In both groups, the CBC used for analysis was obtained from medical records at 5-7 weeks of gestation. In the case group, missed miscarriage was diagnosed by ultrasound 2-5 weeks after CBC sampling. In the control group, women were recruited at the 13-week follow-up visit, where fetal viability was confirmed by ultrasound, and the earlier CBC obtained at 5-7 weeks was used for comparison. Women with major medical comorbidities or other conditions affecting inflammatory markers were excluded. Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR) were calculated from CBC data. Results: Mean NLR was significantly higher in the missed miscarriage group than in controls (3.45 vs. 2.80, P = 0.01). Mean PLR was also higher in the missed miscarriage group (161.2 vs. 125.0), with borderline statistical significance (P = 0.05), whereas LMR did not differ significantly between the two groups. In logistic regression analysis, only NLR was significantly associated with missed miscarriage (OR = 3.65, 95% CI 1.86–7.60). NLR showed the best discriminatory performance; at a cutoff value of > 4.6, it yielded 91% sensitivity and 82% specificity. Conclusion: Elevated NLR was significantly associated with first-trimester missed miscarriage and showed the best discriminatory performance among the studied CBC-derived inflammatory markers. Larger prospective multicenter studies are needed before clinical application can be recommended.